Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (141-150 of 407) with videos related to

Pageof 41
Sort By:
Advances in Neurology|January 1, 1988
Dystonia clinical research center tissue resource facility: investigations on collected tissueM F Brin, C Moskowitz, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Movement disorder in reflex sympathetic dystrophy: a case proven to be psychogenic by surveillance video monitoringR Kurlan, M F Brin, S Fahn
Psychopharmacology|January 1, 1984
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brainA Reches, V Jackson-Lewis, S Fahn
Experientia|August 15, 1984
Little effect of dimethyl sulfoxide on blood-brain barrier to dopamineA Walters, V Jackson-Lewis, S Fahn
Neuropharmacology|October 1, 1985
Clonazepam-induced up-regulation of serotonin1 binding sites in frontal cortex of ratH R Wagner, A Reches, S Fahn
The Laryngoscope|July 1, 1991
Botulinum toxin injections for lingual dystoniaA Blitzer, M F Brin, S Fahn
Brain Pathology (Zurich, Switzerland)|October 1, 1992
The autosomal dominant dystoniasT Gasser, S Fahn, X O Breakefield
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Antiparkinsonian therapies and brain mitochondrial complex I activityS Przedborski, V Jackson-Lewis, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Agreement among movement disorder specialists on the clinical diagnosis of essential tremorS Chouinard, E D Louis, S Fahn
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1985
DL-threo-DOPS as a precursor of noradrenalineA Reches, V Jackson-Lewis, S Fahn
Pageof 41

Showing results (141-150 of 407) with videos related to

Sort By:
Pageof 41
Advances in Neurology|January 1, 1988
Dystonia clinical research center tissue resource facility: investigations on collected tissueM F Brin, C Moskowitz, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Movement disorder in reflex sympathetic dystrophy: a case proven to be psychogenic by surveillance video monitoringR Kurlan, M F Brin, S Fahn
Psychopharmacology|January 1, 1984
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brainA Reches, V Jackson-Lewis, S Fahn
Experientia|August 15, 1984
Little effect of dimethyl sulfoxide on blood-brain barrier to dopamineA Walters, V Jackson-Lewis, S Fahn
Neuropharmacology|October 1, 1985
Clonazepam-induced up-regulation of serotonin1 binding sites in frontal cortex of ratH R Wagner, A Reches, S Fahn
The Laryngoscope|July 1, 1991
Botulinum toxin injections for lingual dystoniaA Blitzer, M F Brin, S Fahn
Brain Pathology (Zurich, Switzerland)|October 1, 1992
The autosomal dominant dystoniasT Gasser, S Fahn, X O Breakefield
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Antiparkinsonian therapies and brain mitochondrial complex I activityS Przedborski, V Jackson-Lewis, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Agreement among movement disorder specialists on the clinical diagnosis of essential tremorS Chouinard, E D Louis, S Fahn
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1985
DL-threo-DOPS as a precursor of noradrenalineA Reches, V Jackson-Lewis, S Fahn
Pageof 41